Source: Annual Congress 2004 - Prognostic factors
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Junker, N. Albrecht, A. Linder, H. N. Macha, M. Thomas, K. M. Mueller (Bochum, Hemer, Muenster, Germany). Different morphological changes in non-small cell lung cancers and their corresponding lymph node metastases after neoadjuvant therapy?. Eur Respir J 2004; 24: Suppl. 48, 3006

Member's Comments

No comment yet.

Related content which might interest you: Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment Source: Eur Respir J 2009; 33: 1383-1388 Year: 2009 Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 602s Year: 2006 Determination of distant metastases in non-small cell lung cancer and factors related to presence of metastasis Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Lymph nodes frozen section in staging of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 534s Year: 2005 Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006 Objective measurement of tumor central location can predict nodal involvement in patients with cT1N0M0 non-small cell lung cancer Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019 Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy Source: Eur Respir J 2006; 28: Suppl. 50, 82s Year: 2006 Management of brain metastases in patients with non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 An usual metastasis of squamous cell lung cancer: intra-abdominal lymph nodes Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Carbohydrate-induced conformational MUC1 tumor-epitope correlates with improved post-surgical survival of non-small cell lung cancer patients with local or distant metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 150s Year: 2006 Neo-adjuvant chemotherapy: level of evidence in early stage and in marginally resectable disease Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010